Clinical Trial Update: Pilot Study of Tocilizumab in Patients With Erdheim-Chester Disease [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial of tocilizumab for Erdheim-Chester disease has been terminated, with the update focusing on the study status rather than results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erdheim-chester Disease

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: Ospedale San Raffaele | Conditions: Erdheim-Chester Disease | Phase 2 | Status: TERMINATED